Sort
50,496 grants matching “lung cancer”
IRE1/XBP1s signaling: a novel essential regulator for bone marrow microenvironmen
$394,328Hongjiao Ouyang · Texas A&M University Health Science Ctr · R01 · FY2017 · CA
Predicting Pulmonary Function Change to Improve Radiation Planning and Outcome
$394,310John Bayouth · University Of Wisconsin-Madison · R01 · FY2013 · CA
Epigenomics Core
$394,295Henry W. Long · Dana-Farber Cancer Inst · P01 · FY2025 · CA
Genetic Susceptibility to Arsenic-induced Skin Cancer
$394,292Habibul Ahsan · University Of Chicago · R01 · FY2007 · CA
Clinical Hematology Research Career Development Program (K12)
$394,277Ellis J Neufeld · Boston Children'S Hospital · K12 · FY2010 · HL
Western New York Cancer Coalition (WNYC2) Center to Reduce Disparities
$394,263Willie Underwood · Roswell Park Cancer Institute Corp · U54 · FY2015 · CA
Control of Breast Cancer Metastasis by Epstein-Barr Virus microRNA
$394,250Kazuko Nishikura · Wistar Institute · R01 · FY2017 · CA
Control of Breast Cancer Metastasis by Epstein-Barr Virus microRNA
$394,250Kazuko Nishikura · Wistar Institute · R01 · FY2016 · CA
Project-1: Defining the mechanisms by which neurons promote breast cancer metastasis
$394,236Sohail F. Tavazoie · Rockefeller University · U54 · FY2022 · CA
The Effect of Isothiocyanate Consumption on NNAL Metabolism in Smokers
$394,193Anna Karolina Hull · Lincoln University · P20 · FY2010 · MD
Improving cancer health equity by targeting physician networks
$394,140Erika Moen · Dartmouth College · R37 · FY2021 · CA
Chip NMR biosensor for molecular analysis of cells
$394,128Ralph Weissleder · Massachusetts General Hospital · R01 · FY2010 · EB
Functional and Structural Studies of CD74 Activation
$394,118Elias Lolis · Yale University · R01 · FY2009 · AI
Investigating the prognostic role of intrinsic immune evasion mechanisms in HNSCC
$394,071Xuefeng Wang · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · DE
Role and mechanism of action of p62/Sqstm1 in Ras-induced tumorigenesis in lung
$394,064Jorge Moscat · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2012 · CA
EVALUATION OF BIOMARKERS PREDICTIVE OF BENEFIT FROM THE PD-1 INHIBITOR MK-3475 IN PATIENTS WITH NON-SMALL CELL LUNG CANCER AND BRAIN METASTASES
$394,034Yale Univ · · FY2015 · Department of the Army
Impact of heterogeneity on response to EGFR T790M inhibitors
$394,033Lecia V. Sequist · Massachusetts General Hospital · R01 · FY2019 · CA
Functional and Structural Studies of CD74 Activation
$394,019Elias Lolis · Yale University · R01 · FY2008 · AI
Dissecting the Mechanism of SETDB1 and its K867 Monoubiquitination in Lung Cancer Progression
$394,014Jia Fang · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
Alpha 5 nAChR is a Risk Factor within the Dopamine System for Nicotine Addiction
$394,000John A. Dani · University Of Pennsylvania · R01 · FY2015 · DA
Fatty acid metabolism regulates ferroptosis in mutant KRAS lung cancer
$393,994Pier P Scaglioni · University Of Cincinnati · R01 · FY2023 · CA
Defining the Critical Function and Regulation of NNMT in Breast Cancer Progression and Metastasis
$393,947Binhua P Zhou · University Of Kentucky · R01 · FY2021 · CA
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$393,933Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Therapeutic Targeting of Breast Cancer Tumor Initiating Cells
$393,933Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
Ancillary T Cell Based Studies in SPIROMICS
$393,907Farrah Kheradmand · Baylor College Of Medicine · R01 · FY2014 · HL